Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
Daniele Roberto GiacobbeCristina MarelliGreta CattardicoChiara FanelliAlessio SignoriGabriele Di MecoVincenzo di PilatoMalgorzata MikulskaMazzitelli MariaAnna Maria CattelanCarlo PallottoDaniela FrancisciAlessandra CalabresiAndrea LombardiAndrea GoriValerio Del BonoChiara AldieriAngela Raffaella LositoFrancesca RaffaelliAndrea CortegianiMarta MilazzoFilippo Del PuenteEmanuele PontaliFrancesco Giuseppe De RosaSilvia CorcioneAlessandra MularoniGiovanna RusselliMauro GiacominiFlavia Badalucco CiottaChiara OltoliniFrancesco Saverio SerinoElena MomessoMichele SpinicciLucia GrazianiCarlo TortiEnrico Maria TrecarichiMarco MerliFederico D'AmicoAnna MarcheseAntonio VenaMatteo Bassettinull nullPublished in: The Journal of antimicrobial chemotherapy (2023)
Our results suggest that the increased mortality in CR-Kp BSI compared with CS-Kp BSI is not (or no longer) dependent on the type of therapy in areas where ceftazidime/avibactam-susceptible KPC-producing isolates are the most prevalent type of CR-Kp.